Constellation Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Constellation Investments’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.6M	Buy	4,450 +175	+4%	+$72.1K	0.29%	72
2015 Q4	$2.32M	Buy	4,275 +75	+2%	+$40.6K	0.43%	54
2015 Q3	$1.95M	Buy	4,200 +25	+0.6%	+$13.4K	0.4%	54
2015 Q2	$2.13M	Buy	4,175 +125	+3%	+$61K	0.41%	57
2015 Q1	$1.83M	Buy	4,050 +125	+3%	+$53K	0.35%	65
2014 Q4	$1.61M	Buy	3,925 +100	+3%	+$39.3K	0.33%	68
2014 Q3	$1.38M	Sell	3,825 -100	-3%	-$33.5K	0.31%	74
2014 Q2	$1.11M	Buy	3,925 +50	+1%	+$14.8K	0.26%	94
2014 Q1	$1.16M	Buy	3,875 +175	+5%	+$53.9K	0.28%	77
2013 Q4	$1.02M	Buy	3,700 +300	+9%	+$86.3K	0.26%	86
2013 Q3	$1.06M	Buy	3,400 +250	+8%	+$65.8K	0.33%	73
2013 Q2	$708K	Buy	+3,150	New	+$734K	0.25%	91

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Constellation Investments's REGN Position: Q1 2016 in Review

Constellation Investments increased its Regeneron Pharmaceuticals (REGN) stake by 4.1% in Q1 2016, buying an estimated $72.1K and bringing the position to 4,450 shares worth $1.6M. The position accounts for 0.29% of the portfolio, ranked #72.

Constellation Investments first reported a position in REGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.32M in Q4 2015. 550 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

Constellation Investments held 4,450 shares of Regeneron Pharmaceuticals worth $1.6M as of Q1 2016.
Constellation Investments bought 175 Regeneron Pharmaceuticals shares in Q1 2016, an estimated $72.1K.
Regeneron Pharmaceuticals made up 0.29% of Constellation Investments's portfolio in Q1 2016, its #72 holding.
Constellation Investments first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Regeneron Pharmaceuticals position peaked at $2.32M in Q4 2015.
550 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.